Rational application of EGFR-TKI adjuvant therapy in patients with completely resected stage IB-IIIA EGFR-mutant NSCLC: a systematic review and meta-analysis of 11 randomized controlled trials. - Zhang, Shu-Ling; Yi, Xiao-Fang; Huang, Le-Tian; Sun, Li; Ma, Jie-Tao; Han, Cheng-Bo (BMC Cancer, 2023)